Skip to content
The Kids Research Institute Australia logo
Donate

Search

Autism researcher named 40 under 40 finalist

Andrew Whitehouse has been listed in the WA Business News 40 under 40 awards recognising accomplished and dynamic young leaders in Western Australia.

Study sheds new light on the ‘autism epidemic’ mystery

Researchers have shown that the so called 'autism epidemic' is due to an increase in the diagnosis of children with less severe behavioural symptoms.

The Kids researcher among Top 5 Under 40

Congratulations to Gail Alvares from our Autism research team who has been named as one the ABC's Top 5 Under 40 scientists in residence.

Hormones in utero influence facial structure

Hormone levels in the womb may determine how masculine or feminine your facial features are as an adult, The Kids Research Institute Australia researchers have found.

Telethon Institute a key player in new national autism research

The Telethon Institute will play a key role in a ground breaking, multi-million dollar Autism research centre announced by Prime Minister Julia Gillard.

Huge hospital burden for kids with intellectual disabilities

New research from the Telethon Institute has shown that children with an intellectual disability are up to 10x more likely to be admitted to hospital.

Andrew Whitehouse: environmental links to autism

Dr Andrew Whitehouse says results from a US study are just the first step when it comes to looking for environmental factors related to autism.

New study shows fetal head size could link to autism

Research has found a link between children with larger head measurements in-utero and a subsequent diagnosis of Autism Spectrum Disorder (ASD) as toddlers.

Better diagnosis leads to higher autism rates

The rapid increase in the number of children diagnosed with autism spectrum disorders (ASD) in Western Australia reflects changes to diagnostic practices

Evaluating placebo responses to intranasal oxytocin in autism: findings from the placebo lead-in phase of a randomised controlled trial

The placebo effect is established in clinical trials, but for paediatric research, questions remain about how to best manage its influence. Within the autism field, data on these issues is sparse. This is particularly important in the oxytocin field where placebo responses are thought to play an important role. This study reports on data from the single-blind, placebo lead-in phase of a randomised controlled trial to investigate the placebo response and its relationship to treatment response in autistic children.